Skip to main content

Table 2 Classification of the 211 HCC patients who underwent hepatectomy in the training cohort

From: Anatomical sites (Takasaki’s segmentation) predicts the recurrence-free survival of hepatocellular carcinoma

Variables

Single segment-HCC (n = 151)

Multiple segments-HCC (n = 60)

Single segment vs. Multiple segments

(P-value)

Left segment

(n = 64)

Middle segment (n = 28)

Right segment (n = 58)

Caudate area (n = 1)

Tumor size (cm)

6.5 ± 4.8

4.0 ± 2.8

4.8 ± 2.5

8.5

7.1 ± 3.3

0.002

Tumor nodule number

     

 < 0.001

 Single

58 (90.6%)

24 (85.7%)

51 (87.9%)

1 (100%)

37 (61.7%)

 

 Multiple (≥ 2)

6 (9.4%)

4 (14.3%)

7 (12.1%)

0

23 (38.3%)

 

Capsulation formation

     

0.540

 Present

39 (60.9%)

15 (53.6%)

34 (58.6%)

0

32 (53.3%)

 

 Absent

25 (39.1%)

13 (46.4%)

24 (41.4%)

1 (100%)

28 (46.7%)

 

Differentiation gradea

     

0.801

 I–II

61 (95.3%)

25 (89.3%)

49 (84.5%)

1 (100%)

55 (91.7%)

 

 III–IV

3 (4.7%)

3 (10.7%)

9 (15.5%)

0

5 (8.3%)

 

MVI

     

1.000

 Present

18 (28.1%)

5 (17.9%)

16 (27.6%)

0

16 (26.7%)

 

 Absent

46 (71.9%)

23 (82.1%)

42 (72.4%)

1 (100%)

44 (73.3%)

 

Liver cirrhosis

     

0.715

 Present

53 (82.8%)

18 (64.3%)

44 (73.3%)

0

50 (83.3%)

 

 Absent

11 (17.2%)

10 (35.7%)

14 (26.7%)

1 (100%)

10 (16.7%)

 

BCLC stage

     

0.161

 0 & A

34 (53.1%)

20 (71.4%)

44 (73.3%)

1 (100%)

27 (45.0%)

 

 B

3 (4.7%)

4 (14.3%)

0

0

16 (26.7%)

 

 C

27 (42.2%)

4 (14.3%)

14 (26.7%)

0

17 (28.3%)

 
  1. BCLC Barcelona Clinic Liver Cancer, MVI microvascular invasion, HCC hepatocellular carcinoma
  2. aEdmondson–Steiner grade